The largest database of trusted experimental protocols

27 protocols using bovine serum albumin (bsa)

1

Isolation and Culture of Murine Monocytes and Microglia

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow-derived monocytes were isolated from C57BL/6J mice 4–8 weeks of age using an established procedure32 . Briefly, bone marrow cells were flushed from extracted tibiae and femurs using harvest solution (PBS with 0.02% Bovine Serum Albumin (STEMCELL), 1 U ml−1 Heparin (STEMCELL), 300 U ml−1 DNase (Worthington)). Homogenised bone marrow suspension was strained through 40-µm mesh and plated on non-tissue culture-treated 15 cm petri dishes. Macrophages were allowed to differentiate for a period of 6 days in DMEM medium supplemented with 10% Fetal Bovine Serum (FBS, Gibco), 1% penicillin-streptomycin (Gibco), and 40 ng ml−1 of recombinant murine CSF1 (Biolegend) before passaging. Macrophages were seeded at density of 1.5 × 106 per well of a six-well plate for all experiments.
Microglial cells were isolated from P2 C57BL/6J mouse pups using a previously established procedure33 (link). Briefly, murine brains were dissected out and meninges were removed under a microscope. Brains were dissociated using 0.25% trypsin with DNase and the resulting single-cell suspension was strained through 40-µm strainers. Cells were seeded in poly-d-lysine-coated T75 flasks, grown in the same medium as BMDMs, and cultured for 10 days, and then collected by vigorous shaking. Microglial cells were seeded at a density of 8 × 105 per well of a six-well plate for all experiments.
+ Open protocol
+ Expand
2

Quantifying IFN-γ in Whole Blood

Check if the same lab product or an alternative is used in the 5 most similar protocols
Plasma levels of IFN-γ from unstimulated and NC-stimulated or S1-stimulated whole blood were determined by IFN-γ enzyme-linked immunosorbent assay (DY285B; R&D systems), according to the manufacturer’s instructions. Plasma was diluted (1:2) in PBS containing 1% bovine serum albumin and 10% rat or mouse serum (Stemcell Technologies and Invitrogen, respectively) to minimize unspecific reactivity. A reduced concentration of mouse serum in an additional standard curve was used to normalize the data in samples diluted in mouse serum, because this matrix interfered with the standard curve. Optical density was measured at 450 and 570 nm, using a FLUOstar Omega plate reader (BMG). Results are presented as peptide-induced IFN-γ obtained by subtracting levels of IFN-γ in unstimulated samples from those in peptide-stimulated samples. Levels below the LOD (<10 pg/mL) were set to 50% of the LOD.
+ Open protocol
+ Expand
3

Preparation of Conjugated Fatty Acid Solutions

Check if the same lab product or an alternative is used in the 5 most similar protocols
10% BSA solution was prepared by dissolving bovine serum albumin in NSA medium (Stem Cell Technologies) without supplements. Next, this solution was incubated in a water bath at 37°C until completely dissolved and then sterile-filtered using a 0.2 micron filter. In the meantime, 100mM stocks of fatty acids were prepared in 50% ethanol (sodium palmitate) or 100% ethanol (all other fatty acids). Subsequently, these were diluted in 10% BSA to obtain 2mM sodium palmitate and 1mM palmitoleate and sapienate. As control, 100% ethanol was diluted 1:50 in 10% BSA and processed the same way as fatty acids. Next, they were incubated in water bath at 37°C for at least 1 hour to allow conjugation. Conjugated fatty acids were aliquoted to avoid freeze-thaw cycles and stored at -20°C.
+ Open protocol
+ Expand
4

Cryopreserved CD34+ Cell Culture Optimization

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cryopreserved primary CD34+ cells were recovered from liquid nitrogen as previously described10 (link) and cultured overnight in a humidified incubator at 37 °C with 5% CO2 in SFM consisting of Iscove Modified Dulbecco Medium (Sigma-Aldrich) containing serum substitute (bovine serum albumin, insulin, transferrin [BIT]; Stem Cell Technologies), 0.1 μM 2-mercaptoethanol (Sigma-Aldrich), penicillin-streptomycin, L-glutamine plus a high concentration growth factor (5GF) cocktail containing 100 ng/mL Flt3-ligand (Flt3-L), 100 ng/mL stem cell factor (SCF), 20 ng/mL interleukin-3 (IL-3), 20 ng/mL IL-6 (Stem Cell Technologies) and 20 ng/mL granulocyte-colony stimulating factor (G-CSF; Chugai Pharma) to maximize cell recovery. In selected experiments following overnight culture, cells were washed and cultured in SFM supplemented with 5GF cocktail, a physiological growth factor cocktail comprising 5 ng/mL Flt3-L, 5 ng/mL SCF, 1 ng/mL IL-3, 1 ng/mL IL-6 and 1 ng/mL G-CSF (LGF) or SFM alone.
+ Open protocol
+ Expand
5

Hematopoietic Lineage Differentiation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
After immunomagnetic separation, CD34+ cells were seeded in 24-well plates at a density of 5 × 105/mL in IMDM added with 20% BIT serum substitute (bovine serum albumin, insulin, and transferrin; StemCell Technologies, Vancouver, BC, Canada) in order to set up erythroid (SCF 10 ng/mL and EPO 0.4 U/mL, adapted from Tenedini et al. [39 (link)]), megakaryocyte (TPO 50 ng/mL, SCF 10 ng/mL, adapted from Tenedini et al. [39 (link)]), granulocyte (GCSF 25 ng/mL, SCF 10 ng/mL, adapted from Kandilci et al. [40 (link)]) and monocyte/macrophage [40 (link)] (MCSF 100 ng/mL, SCF 20 ng/mL, IL6 20 ng/mL and FLT3L 50 ng/mL, all cytokines from Miltenyi Biotec, Bergisch Gladbach, Germany) unilineage cultures. The medium was replaced every 3 days. CD34+ cells differentiation was monitored by morphological analysis of MGG-stained cytospins and by flow-cytometric analysis of differentiation marker expression. miR-34a-5p, LEF1 and NR4A2 expression levels were detected by Real-Time RT-qPCR at different time points (i.e., day 0, 4, and 8) after the seeding of cells in erythroid, megakaryocyte, granulocyte or monocyte/macrophage unilineage cultures.
+ Open protocol
+ Expand
6

Generation of hiPSCs from CD34+ Bone Marrow Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
To obtain hiPSCs, CD34+ cells were purified from primary human bone marrow (BM) cells (Allcells, Emeryville, CA, USA) via immunomagnetic separation (human CD34 microbeads; Miltenyi Biotec, Bergisch Gladbach, Germany). Isolated CD34+ BM cells were transduced with OCT3/4, SOX2, KLF4, and c-Myc sendai virus (Cytotune 2.0; Thermo Fisher Scientific, Waltham, MA, USA) in Iscove’s modified Dulbecco’s medium (Gibco) supplemented with 15% bovine serum albumin, 1× BIT (Stemcell Technologies, Vancouver, Canada), 1% non-essential amino acids (Gibco), 100 ng/mL stem cell factor, 100 ng/mL thrombopoietin, 100 ng/mL Flt-3 ligand, and 20 ng/mL interleukin-3 (R&D Systems, Minneapolis, MN, USA) as previously described (19 (link), 20 (link)). After a 48 h incubation, transduced CD34+ BM cells were maintained on matrigel (BD Biosciences, Franklin Lakes, NJ, USA)-coated plates with TeSR-E8 iPSC culture medium (Stemcell Technologies). hiPSC colonies were manually selected ~15 days after transduction and expanded in TeSR-E8 medium.
+ Open protocol
+ Expand
7

Methylcellulose-Based Hematopoietic Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Non-adherent cells were removed from the LTBMC flasks and suspended at l×lO6 cells/ml with 5×l04 cells/dish were plated in triplicate in semi-solid medium consisting of methylcellulose in Iscove’s modified Dulbecco’s medium (IMDM) 10% FBS, 10% bovine serum albumin (BSA), L-glutamine, 3 U/ml erythropoietin, and 2-mercaptoethanol (Stem Cell Technology, Vancouver, BC, CA). WEHI-3 conditioned medium was added as a source of I1–3 (15 (link)). Colony-forming unit granulocyte-macrophage (CFU-GM) of 50 cells or greater were counted on days 7 and 14 after plating. Fresh marrow colonies were subdivided for CFU-GM, burst forming unit erythroid (BFUe) and colony-forming unit granulocyte-erythroid-megakaryocyte-macrophage (CFU-GEMM)
+ Open protocol
+ Expand
8

Lentiviral Knockdown of Mtf2 in Mouse Hematopoietic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Adult mouse BM was isolated and lineage-depleted to enrich for stem and progenitor cells (Stem Cell Technologies). Cells were maintained in Iscove's modified Dulbecco's media containing bovine serum albumin, insulin and transferrin (Stem Cell Technologies), 100 U/mL penicillin–streptomycin (ThermoFisher), stem cell factor (SCF; 50 ng/mL), thrombopoietin (10 ng/mL), FLT3 (10 ng/mL) and interleukin-6 (IL-6; 10 ng/mL). Growth factors were purchased from Peprotech. On day 1 of infection, cells were incubated with polybrene (6 mg/mL) for 2 h at 37 °C, and then combined with viral supernatants containing either a green fluorescent protein (GFP)-tagged Mtf2 shRNA clone or a scrambled shRNA control (ThermoFisher). Cells were pelleted at 400 × g for 20 min, and then maintained at 37 °C. On day 2, infection was repeated. Cells were grown for 3 days using a fed-batch culture system and then sorted according to GFP expression. High GFP cells were fixed in 4% PFA, permeabilized with 0.3% Triton and labeled with antibodies against Mtf2 (Genway), Ezh2 (Cell Signaling), Suz12 (Millipore) or H3K27me3 (Millipore) and stained with the appropriate secondary antibodies. Protein expression was determined by flow cytometry compared with an isotype-only control. Data analysis compared mean fluorescent intensity values using a ratio paired t test.
+ Open protocol
+ Expand
9

Characterizing AML and Cord Blood Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
AML bone marrow samples and human cord blood (CB) units were collected per institutional guidelines (CPP IdF2 N°2015-08-11 MS3 DC), with a written informed consent from donors in accordance with the Declaration of Helsinki. Handling, characterization, and storage of patient samples were performed by Cochin Hospital’s Cell Biobank. For samples from patients with AML, the selection criterion was high levels of FLT3-internal tandem duplication (ITD):wild type (WT) ratio (ITD:WT > 0.5, supplemental Table 3). After thawing, AML bone marrow mononuclear cells were kept in culture in Iscove modified Dulbecco medium supplemented with bovine serum albumin, insulin, and transferrin (Stem Cell Technologies), thrombopoietin peptide (20 nM), human interleukin-3 (10 ng/mL), human stem cell factor (50 ng/mL), and human FLT3-L (50 ng/mL) as previously described.17 (link) CB CD34+ cells were purified per the manufacturer’s recommendations (Miltenyi), and cultured in Iscove modified Dulbecco medium, as previously described.22 (link)
+ Open protocol
+ Expand
10

Ex Vivo Expansion of AML Stem Cells and Hematopoietic Stem Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Frozen AML mono-nucleated patients cells were thawed at 37 °C in Iscove's modified Dulbecco's medium containing 20% fetal bovine serum and DNase I (100 μg/ml). Cells were then cultured in a medium designed to support primary AML LSC activity, as previously reported:13 (link), 16 (link) Iscove's modified Dulbecco's medium, 15% BIT (bovine serum albumin, insulin, transferrin; StemCell Technologies, Vancouver, British Columbia, Canada), 100 ng/ml stem cell factor, 50 ng/ml FLT3-L, 20 ng/ml, interleukin-3, 20 ng/ml granulocyte colony-stimulating factor (Shenandoah Biotechnology, Warwick, PA, USA), 10−4M β-mercaptoethanol, 500 nM SR1 (Alichem P&C, Monza MB, Italy), 500 nM UM729 (synthesized at the Medicinal Chemistry Core Facility at the Institute for Research in Immunology and Cancer), gentamicin (50 μg/ml) and ciprofloxacin (10 μg/ml).
Human CD34+ cells were cultured as previously described.29 (link) Briefly, cells were cultured in HSC expansion media consisting of StemSpan SFEM (StemCell Technologies) supplemented with human 100 ng/ml stem cell factor, 100 ng/ml FMS-like trysine kinase 3 ligand (FLT3LG), 50 ng/ml thrombopoietin (R&D Systems, Minneapolis, MN, USA) and 10 μg/ml low-density lipoproteins (StemCell Technologies).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!